Bottom line
GGHCX vs HGHAX: the short answer
GGHCX (INVESCO Health Care Fund) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 52% by weight.
GGHCX is cheaper at 1.07% vs 1.33% — a difference of $26 a year per $10,000 invested.
Updated Nov 19, 2026
GGHCX vs HGHAX side by side
| GGHCX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 1.33% |
| Annual cost per $10k | $107 | $133 |
| 10-yr cost on $10k (prospectus) | $1,784 | $2,063 |
| Max front load | 5.5% | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +9.2% | — |
| 5-yr return (annualized) | +2.6% | — |
| 10-yr return (annualized) | +5.8% | — |
| Best quarter | +19.6% | +20.9% |
| Worst quarter | −16.5% | −15.7% |
| Net assets (fund) | $1.2B | $772.2M |
| Number of holdings | 82 | 80 |
| Portfolio turnover | 59% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GGHCX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +15.5% | +15.6% | −0.1% |
| 2024 | +4.0% | 0.0% | +4.0% |
| 2023 | +3.1% | +3.8% | −0.7% |
| 2022 | −13.5% | −11.7% | −1.8% |
| 2021 | +12.2% | +10.0% | +2.2% |
| 2020 | +14.5% | +22.6% | −8.1% |
| 2019 | +32.0% | +33.3% | −1.3% |
| 2018 | +0.5% | −3.0% | +3.5% |
| 2017 | +15.5% | +21.6% | −6.1% |
| 2016 | −11.7% | −8.6% | −3.1% |
Source: Fund prospectus bar charts
Holdings overlap
9 of GGHCX's top 25 holdings also appear in HGHAX's top 25.
| Holding | GGHCX | HGHAX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 12.03% |
| Johnson & Johnson | 6.76% | 6.75% |
| UnitedHealth Group Inc. | 6.17% | 4.74% |
| Merck & Co., Inc. | 4.59% | 6.00% |
| AbbVie Inc. | 4.03% | 4.21% |
| CVS Health Corp. | 2.52% | 2.84% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.64% |
| Edwards Lifesciences Corp. | 1.56% | 2.48% |
| Thermo Fisher Scientific Inc. | 1.55% | 1.58% |
Source: SEC Form N-PORT
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between GGHCX and HGHAX?
Which is cheaper, GGHCX or HGHAX?
Should I own both GGHCX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.